Carlos Duran Salinas

Assistant Professor

Biography

Carlos E. Durán (1981) is an Ecuadorian medical doctor with experience in the fields of Drug Utilization Research, Public Health, Pharmaceutical Policy, and Therapeutic Information to prescribers. He got his doctoral degree at Ghent University, Belgium. Since 2021, he holds a position as Assistant Professor in the department of Data Science & Biostastistics at Julius Center for Health Sciences and Primary Care at University Medical Center Utrecht, the Netherlands. In the department, he is part of a team of researchers, statisticians, and programmers conducting pharmacoepidemiological studies in large electronic healthcare databases. He is also affiliated as associate researcher to the Think Tank Medicines, Information and Power at National University of Colombia. For the last 14 years, he has been the Editor-in-chief of the Ecuadorian Green Book of Medicines, an independent therapeutic formulary.

Recent publications

Efficacy and safety of SARS-CoV-2 vaccination in pregnancy to prevent COVID-19 in mothers and early infancy Odette de Bruin, Emily Wem Phijffer, Fariba Ahmadizar, Nicoline At Van der Maas, Joanne G Wildenbeest, Miriam Cjm Sturkenboom, Louis J Bont, Carlos E Durán, Kitty Wm Bloemenkamp
The Cochrane database of systematic reviews, 2025, vol. 2025, p.1-12
Drug utilization research in South and Central America Claudia Garcia Serpa Osorio-de-Castro, Luciane Cruz Lopes, Carlos E. Durán
2024, p.569-573
Intervention studies in drug utilisation research Tanja Mueller, Giampiero Mazzaglia, E. Durán Carlos
2024, p.73-81
Incidence of severe and non-severe SARS-CoV-2 infections in children and adolescents Carlos E. Durán, Fabio Riefolo, Rosa Gini, Elisa Barbieri, Davide Messina, Patricia Garcia, Mar Martin, Felipe Villalobos, Luca Stona, Juan José Carreras, Arantxa Urchueguía, Elisa Correcher-Martínez, Jing Zhao, Angela Lupattelli, Hedvig Nordeng, Miriam Sturkenboom
European Journal of Pediatrics, 2024, vol. 184
Corrigendum to “A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases” [Vaccine 42 (12) (2024) 3039–3048, (S0264410X2400330X), (10.1016/j.vaccine.2024.03.043)] Anna Schultze, Ivonne Martin, Davide Messina, Sophie Bots, Svetlana Belitser, Juan José Carreras-Martínez, Elisa Correcher-Martinez, Arantxa Urchueguía-Fornes, Mar Martín-Pérez, Patricia García-Poza, Felipe Villalobos, Meritxell Pallejà-Millán, Carlo Alberto Bissacco, Elena Segundo, Patrick Souverein, Fabio Riefolo, Carlos E. Durán, Rosa Gini, Miriam Sturkenboom, Olaf Klungel, Ian Douglas
Vaccine, 2024, vol. 44
Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example Sophie H Bots, Svetlana Belitser, Rolf H H Groenwold, Carlos E Durán, Judit Riera-Arnau, Anna Schultze, Davide Messina, Elena Segundo, Ian Douglas, Juan José Carreras, Patricia Garcia-Poza, Rosa Gini, Consuelo Huerta, Mar Martín-Pérez, Ivonne Martin, Olga Paoletti, Carlo Alberto Bissacco, Elisa Correcher-Martínez, Patrick Souverein, Arantxa Urchuequía, Felipe Villalobos, Miriam C J M Sturkenboom, Olaf H Klungel
American Journal of Epidemiology, 2024, vol. 194, p.208-219